RECCHIA, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 6.704
EU - Europa 3.348
AS - Asia 908
OC - Oceania 45
AF - Africa 11
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.026
Nazione #
US - Stati Uniti d'America 6.636
IT - Italia 1.051
GB - Regno Unito 940
SE - Svezia 459
CN - Cina 325
DE - Germania 268
SG - Singapore 183
HK - Hong Kong 165
UA - Ucraina 140
FR - Francia 131
FI - Finlandia 97
TR - Turchia 91
BG - Bulgaria 60
BE - Belgio 46
AU - Australia 35
CA - Canada 33
NL - Olanda 31
BZ - Belize 28
ID - Indonesia 27
LT - Lituania 27
VN - Vietnam 25
JP - Giappone 23
IE - Irlanda 19
IR - Iran 19
IN - India 16
CZ - Repubblica Ceca 14
CH - Svizzera 13
AT - Austria 10
KR - Corea 10
NZ - Nuova Zelanda 10
MY - Malesia 9
ZA - Sudafrica 9
RU - Federazione Russa 7
SI - Slovenia 7
MX - Messico 6
RO - Romania 6
ES - Italia 5
GR - Grecia 4
PK - Pakistan 4
PT - Portogallo 4
EU - Europa 3
TW - Taiwan 3
AL - Albania 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
LB - Libano 2
NO - Norvegia 2
TH - Thailandia 2
UY - Uruguay 2
BD - Bangladesh 1
DK - Danimarca 1
HR - Croazia 1
IL - Israele 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 11.026
Città #
Fairfield 1.040
Southend 746
Chandler 598
Woodbridge 586
Houston 489
Ashburn 473
Seattle 377
Cambridge 360
Ann Arbor 336
Wilmington 307
Jacksonville 299
Dearborn 278
Nyköping 274
Modena 194
Hong Kong 160
Singapore 131
Beijing 106
San Diego 95
Bologna 79
Princeton 71
San Jose 59
Sofia 59
Helsinki 56
Bremen 55
Eugene 52
New York 49
Izmir 45
Brussels 44
Redwood City 32
Shanghai 31
Los Angeles 30
Milan 30
Des Moines 29
Falls Church 29
London 29
Belize City 28
Jakarta 27
Rome 27
Dong Ket 25
Paris 21
Bari 20
Buffalo 19
Boardman 18
Parma 18
Hefei 17
Phoenix 17
Las Vegas 16
Chicago 14
Dublin 13
Fremont 13
San Francisco 13
Albuquerque 12
Brno 12
Camden 12
Saint Louis 12
Toronto 12
Norwalk 11
Frankfurt am Main 10
Nanjing 10
Napoli 10
Valsamoggia 10
Wuhan 10
Canberra 9
Kinde 9
Minerbio 9
San Giuliano Milanese 9
Auckland 8
Castelfranco Emilia 8
Kilburn 8
Medesano 8
Porretta Terme 8
Soave 8
Trento 8
Vienna 8
Columbus 7
Goito 7
Munich 7
Ottawa 7
Adelaide 6
Amstelveen 6
Ankara 6
Dallas 6
Hounslow 6
Jinan 6
Mountain View 6
Padova 6
Reggio Emilia 6
Reggio Nell'emilia 6
Turin 6
Vicenza 6
Empoli 5
Forlì 5
Grafing 5
Gunzenhausen 5
Kunming 5
Melbourne 5
Montereale Valcellina 5
Piacenza 5
Ravenna 5
Roncoferraro 5
Totale 8.305
Nome #
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 417
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 291
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 287
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 261
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 260
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 257
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 253
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 252
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 252
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 250
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 248
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 244
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 231
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 221
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 210
Long-Term Skin Regeneration From a Gene-Targeted Human Epidermal Stem Cell Clone 209
Nuclear architecture dictates HIV-1 integration site selection 207
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 203
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 201
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy 199
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 197
Tracking gene-modified T cells in vivo. 197
A single epidermal stem cell strategy for safe ex vivo gene therapy 186
AAV-CRISPR Persistence in the Eye of the Beholder 185
Site-specific integration into the human genome: Ready for clinical application? 181
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 179
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 176
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 176
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 172
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 167
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 166
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 163
Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration 163
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 162
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 162
Defining the lentiviral integrome in human hematopoietic cells 160
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. 153
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells 153
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 149
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector 149
Comprehensive genomic access to vector integration in clinical gene therapy. 146
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 137
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 135
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 134
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 134
Transcriptional and epigenetic analyses of the DMD locus reveal novel cisâ acting DNA elements that govern muscle dystrophin expression 133
Site-specific integration by the adeno-associated virus rep protein 132
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 132
Targeted integration of a large transgene cassette by TALEN and ZFN-mediated homologous recombination. 130
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector 123
Gene editing prospects for treating inherited retinal diseases 120
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 117
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 117
Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination 115
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 109
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 109
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 100
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 94
The Journal of Gene Medicine European Society of Gene Therapy Young Investigator Award 2004 88
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 65
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 65
Corrigendum to: “Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression”. [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138–1147.] (Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2017) 1860(11) (1138–1147), (S1874939917301359), (10.1016/j.bbagrm.2017.08.010)) 60
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 56
Collagen VII gene delivery via an Adeno-Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 52
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 51
TALEN-mediated in situ correction of a genetic defect by homologous recombination into the native locus 48
Engineered nucleases-mediated in situ correction of a genetic defect by homologous recombination into the native locus 47
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 44
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 30
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 29
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 27
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 24
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 24
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 13
Totale 11.289
Categoria #
all - tutte 47.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.957 0 0 78 144 266 345 382 250 199 88 136 69
2020/20212.067 231 53 155 179 129 232 170 202 97 288 217 114
2021/20221.756 77 173 208 102 113 101 132 123 145 112 279 191
2022/20231.921 211 207 165 218 243 257 50 160 207 25 96 82
2023/20241.186 53 72 93 99 217 70 113 147 28 84 83 127
2024/2025214 105 46 63 0 0 0 0 0 0 0 0 0
Totale 11.289